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Abstract
Background: Diols are important monomers for the production of plastics and polyurethanes, which are widely
used in our daily life. The medium-chain diols with one hydroxyl group at its subterminal end are able to confer
more flexibility upon the synthesized materials. But unfortunately, this type of diols has not been synthesized so far.
The strong need for advanced materials impelled us to develop a new strategy for the production of these novel
diols. In this study, we use the remodeled P450BM3 for high-specificity production of 1,7-decanediol.
Results: The native P450BM3 was capable of converting medium-chain alcohols into corresponding α, ω1-, α,
ω2- and α, ω3-diols, with each of them accounting for about one third of the total diols, but it exhibited a little or
no activity on the short-chain alcohols. Greatly improved regiospecificity of alcohol hydroxylation was obtained by
laboratory evolution of P450BM3. After substitution of 12 amino acid residues (J2-F87A), the ratio of 1,7-decanediol
(ω-3 hydroxylation) to total decanediols increased to 86.8 % from 34.0 %. Structure modeling and site-directed
mutagenesis demonstrated that the heme end residues such as Ala78, Phe87 and Arg255 play a key role in
controlling the regioselectivity of the alcohol hydroxylation, while the residues at the mouth of substrate binding
site is not responsible for the regioselectivity.
Conclusions: Herein we employ an engineered P450BM3 for the first time to enable the high-specificity biosynthesis
of 1,7-decanediol, which is a promising monomer for the development of advanced materials. Several key amino
acid residues that control the regioselectivity of alcohol hydroxylation were identified, providing some new insights
into how to improve the regiospecificity of alcohol hydroxylation. This report not only provides a good strategy for
the biosynthesis of 1,7-decanediol, but also gives a promising approach for the production of other useful diols.
Keywords: P450BM3, Alcohol hydroxylation, Escherichia coli, Diols, 1,7-decanediol, Regiospecificity
Abbreviations: E. coli, Escherichia coli; GC-MS, Gas chromatography-mass spectrometry; IPTG, Lsopropyl β-D-
thiogalactoside; Kan, Kanamycin; PCR, Polymerase chain reaction.
Background
Diols are of great importance in the manufacture of plas-
tics and polyurethanes, which have molded our society in
many ways that make our life much easier [1]. The biosyn-
thesis of short-chain diols such as 1,3-propanediol and
1,4-butanediol has been well developed [2–5], while the
long-chain α, ω-diols such as 1,14-tetradecanediol and
1,16-hexadecanediol can be made by the catalytic hydro-
genation of long-chain dicarboxylate esters. The medium-
chain diols with one subterminal hydroxyl group, for ex-
ample, 1,7-decanediol, which confer more flexibility upon
the synthesized materials, are promising monomers for
the synthesis of polymers with better properties. But un-
fortunately, this type of diols has not yet been synthesized
with either chemical or biological method. The strong
market demand for new polymers drives us to develop a
strategy for the synthesis of these diols.
To obtain the carbon backbones, we paid attention to
the straight-chain fatty alcohols, whose biosynthesis has
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been well developed in recent years [6–8]. To finally get
the desired diols, an additional hydroxyl group needs to
be added to the subterminal carbon of the monohydric
alcohols. But it is too difficult for the inorganic catalysts
to catalyze the oxidation of a specific subterminal carbon
of the monohydric alcohols, as each of the subterminal
carbons almost has the same chemical contexts, and the
inorganic catalysts usually exhibit poor selectivity. So the
biocatalyst was considered as a priority. In seeking such
a biocatalyst for the conversion of monohydric alcohols
to corresponding diols, P450BM3 seems to be a promis-
ing enzyme, which naturally catalyzes the conversion of
long-chain fatty acids to corresponding hydroxyfatty
acids [9, 10]. P450BM3 is highly soluble in cytosolic envir-
onment, and has high catalytic rates and expression level
in engineered E. coli, which is the most widely used host
for the bioproduction of chemicals [11, 12]. These ad-
vantages make it an ideal biocatalyst for biotechnological
application. And more importantly, its variants have
shown to be able to utilize a wide range of other sub-
strates. The P450BM3 variant 35-E11, whose 17 amino
acid residues were substituted, was found to be capable
of converting ethane to ethanol [11], and a series of
P450BM3 variants were reported the improved activities
on non-natural substrates naphthalene, pentane, p-
cymene and propylbenzene [13]. These findings suggest
that P450BM3 has stunning flexibility in substrate prefer-
ence. In addition, protein engineering has been widely
used as a strategy in the biological production of
chemicals [14, 15]. Therefore, an improved regioselec-
tivity for alcohol hydroxylation at ω-3 position can be
expected by remodeled P450BM3 (Fig. 1).
In this study, we are reporting a strategy for high-
specificity synthesis of α, ω3-diols from renewable
medium-chain fatty alcohols. To improve the regioselec-
tivity for alcohol hydroxylation at ω-3 position, we gen-
erated a series of P450BM3 variants by laboratory
evolution. We also identified several key amino acid resi-
dues that control the regioselectivity of alcohol hydrox-
ylation, and discussed the reason why these residues
play a key role in determining the regioselectivity by
structural analysis.
Results and discussion
Substrate specificity and regioselectivity of P450BM3
The P450BM3 was chosen as the starting enzyme for the
conversion of alcohols to diols. So the engineered E. coli
that overexpresses the native P450BM3 was constructed
as the biocatalyst to test P450BM3’s ability of alcohol hy-
droxylation. The heptanol and decanol were firstly used
as the substrates for testing the activity of P450BM3, as
the medium chain diols are of more interests for the de-
velopment of new polymers. P450BM3 exhibited high ac-
tivities towards these substrates and produced almost an
equivalent amount of α, ω1-, α, ω2- and α, ω3-diols,
exhibiting the same regioselectivity as its native fatty
acid substrates (Figs. 2 and 3). But when using pentanol
as the substrate, only a tiny amount of 1,4-pentanediol
Fig. 1 Schematic representation of the substrate specificities and regioselectivities of the native P450BM3 and the remodeled P450BM3. The native
P450BM3 has a substrate preference for C12-C18 fatty acids and evenly oxidizes the ω-1, ω-2 and ω-3 carbons of the fatty acid substrates (a), while
the remodeled P450BM3 exhibits a greatly improved regiospecificity of decanol hydroxylation, with 1,7-decanediol as the dominant product (b)
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was obtained (Fig. 2), suggesting P450BM3 has a different
regioselectivity for short-chain alcohols. No activity was
observed when using propanol and butanol as the
substrates.
As the typical substrates of P450BM3 are long-chain
fatty acids [16], it is not surprising that the short-chain
fatty alcohols are poor substrates for P450BM3. Arg
47 and
Tyr51 were thought to interact with the carboxylate
group of the fatty acid substrates [17, 18]. Our finding
that P450BM3 is also capable of utilizing fatty alcohols
demonstrates that the interaction between Arg47/Tyr51
and carboxylate group is not so strong, and Arg47/Tyr51
is not involved in determining the substrate specificity of
P450BM3. If Arg
47/Tyr51 is responsible for stabilizing the
carboxylate group of the fatty acid substrates, the carb-
oxylate group needs to be recognized by the two amino
acid residues, and P450BM3 will not be able to oxidize
those hydrocarbons without carboxylate group. There-
fore, the size of the substrate-binding pocket plays an
important role in determining the substrate specificity of
P450BM3, given that the P450BM3 has no activity towards
short-chain alcohols and alkanes [19].
Substrate specificity and regioselectivity of P450BM3J
For the high-specificity production of the α, ω3-diols,
the native P450BM3 needs to be modified to change its
Fig. 2 GC-MS analysis of diols in the cultures. When pentanol was used as substrate, both BM3 and BM3J produced 1,4-pentanediol as the only
product (a, d). When heptanol and decanol were used as substrates, BM3J produced much more 1,4-heptanediol (b, e) and 1,7-decanediol (c, f)
than BM3, respectively
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regioselectivity for alcohol hydroxylation. The regioselec-
tivity is connected with the substrate orientation, which
could be changed when the substrate channel of
P450BM3 is constrained. It was found that a P450BM3
variant (P450BM3J), which contains 10 amino acid substi-
tutions (V78A, T175I, A184V, F205C, S226R, H236Q
E252G, R255S, A290V, L353V) with respect to the native
P450BM3, changed its substrate preferences for shorter
alkanes (C4-C8) when compared with the native
P450BM3, which exhibited a substrate preference for
Cn > 8 alkanes [19]. It could be expected that P450BM3J
will have a higher priority for ω3 hydroxylation when using
a longer-chain alcohol substrate. So we generated another
engineered E. coli BM3J that overexpressed P450BM3J. The
same as BM3, BM3J had no activity on propanol and buta-
nol, and exhibited a low activity on pentanol, with 1,4-pen-
tanediol as the only product (Fig. 2). But when using
heptanol and decanol as substrates, BM3J produced more
1,4-heptanediol and 1,7-decanediol than BM3, with 1,4-
heptanediol and 1,7-decanediol accounting for 50.1 and
64.5 % of total heptanediols and decanediols, respectively
(Figs. 2 and 3).
To examine if the increased ω-3 hydroxylation is mainly
attributed to a specific amino acid substitution, we made
10 single mutants that correspond to the 10 amino acid
substitutions of P450BM3J, namely, V78A, T175I, A184V,
F205C, S226R, H236Q, E252G, R255S, A290V and L353V.
The ratio of 1,7-decanediol to total decanediols increased
from 34.0 % in BM3 to ~50 % in R255S (Fig. 3), suggesting
the increased ratio of 1,7-decanediol to total decanediols
in BM3J is mainly attributed to the substitution of Arg255
to Ser255, which allows the ω terminal carbon of the
decanol substrate to move a little closer to the Ser255, and
in the meanwhile to move a little farther away from the
heme. This movement makes the ω-1 carbon deviate from
its best position for hydroxylation, and thus decreases the
efficiency of ω-1 hydroxylation. The other 9 amino acid
substitutions may have a combined effect on the constric-
tion of the substrate-binding channel and the change of
the substrate orientation (Fig. 4b).
The effect of heme end residues on the regioselectivity of
P450BM3J
To further improve the regioselectivity of P450BM3J, we
need to further constrict the substrate-binding channel.
The Val78 in P450BM3 is located near the ω terminus of
fatty acid substrates, so it may be vital in controlling the
substrate orientation. Fatty alcohol substrates should
have a quite similar substrate orientation in the active
site to the fatty acid substrates, which can be reflected
by the regioselectivity for heptanol and decanol hydrox-
ylation. The substitution of Val78 in P450BM3 to Ala
78 in
P450V78A nearly does not change the regioselectivity for
decanol, as alanine has a similar property to valine. But
when the Ala78 in P450BM3J was substituted to Phe
78,
yielding a variant J2, the ratio of 1, 7-decanediol (ω-3 hy-
droxylation) to total decanediols further increased to
76.3 % from 64.5 % in BM3J (Fig. 5). The phenyl group
of Phe78 creates a narrower space between Phe78 and the
heme. This conformational change forced the carbon
chain bend, made the ω, ω-1 and ω-2 terminal carbons
move farther away from the heme, and finally resulted in
the decrease of undesired ω-1 and ω-2 hydroxylation
(Fig. 4c). Therefore, the residues located around the
heme end of the substrate-binding channel indeed play
more important roles in determining the regioselectivity
Fig. 3 Regiospecificities of the native P450BM3, P450BM3J and corresponding 10 single mutants of P450BM3J. Decanol was used as the substrate,
and 1,7-, 1,8- and 1,9-decanediols were analyzed by GC-MS. The ratio of 1,7-decanediol to total decanediols increased from 34.0 % in BM3 to
~50 % in R255S, suggesting the increased ratio of 1,7-decanediol to total decanediols in BM3J is mainly attributed to the substitution of Arg255 to
Ser255. The other 9 amino acid substitutions may have a combined effect on the constriction of the substrate-binding channel and the change of
the substrate orientation
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of the alcohol hydroxylases for medium-chain alcohol
substrates.
To test this hypothesis, two residues, Arg47 and Phe87,
were chosen for further modification. Arg47 is located at
the mouth of substrate binding site and its guanidinium
group is thought to provide an important ion-pair inter-
action with the carboxylate group of the fatty acid sub-
strates [20], while Phe87 is located above the heme and
is known to be an important factor in determining the
regioselectivity of substrate hydroxylation [21]. The sub-
stitution of Arg47 to Leu47 was found to increase the
hydroxylase activity towards pentane and propylbenzene
[13]. The R47L mutation was then incorporated into the
variant J2, generating a new variant J2-R47L. As
expected, the regiospecificity profile of J2-R47L was
nearly the same as that of J2 (Fig. 5), demonstrating the
substitution of Arg47 to Leu47 did not change the
substrate orientation and had little connection with the
regioselectivity for alcohol substrates. But when the
Phe87 was substituted to Ala87 (J2-F87A), the ratio of
1,7-decandediol to total decanediols further increased to
86.8 % (Fig. 5). The substitution of Phe87 to Ala87
Fig. 4 Three-dimensional structures of P450BM3 and its variants. P450BM3 heme domain with palmitoleic acid bound was obtained from 1FAG (a).
SWISS-MODEL derived homology models of P450BM3 variant structures, using 1FAG as the template (b, c, d). The amino acid residues involved in
laboratory evolution are depicted in stick symbols. B, P450BM3J; C, P450J2; D, P450J2-F87A
Fig. 5 Regioselectivities of native P450BM3 and its variants for
decanol. Decanol was used as substrate, and product decanediols
were analyzed by GC-MS. 1,7-, 1,8- and 1,9-decanediols represent
ω-3, ω-2 and ω-1 hydroxylation, respectively. BM3 expresses the
native P450BM3, while BM3J, J2, J2-R47L and J2-F87A express different
P450BM3 variants
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released the space for the α-terminus of decanol to move
towards the heme, and in the meanwhile made the ben-
zene ring of Phe78 rotate away from the ω terminus of
decanol (Fig. 4d). This incident allowed the ω, ω-1 and
ω-2 terminal carbons of decanol to further move away
from the heme, leading to the increased distribution of
1,7-decandediol. The heme end residues are responsible
for contraction or expansion of the hydrophobic pocket,
so they can affect the alcohol orientation in the
substrate-binding channel and finally control the regio-
selectivity of the alcohol hydroxylation.
Conclusions
The engineering strategy described above inaugurates a
new realm for the high-specificity production of 1,7-
decanediol, which is a promising monomer for the
development of advanced materials. The desired 1,7-
decanediol was finally produced, being the first successful
report on the biosynthesis of diols with one hydroxyl
group at the subterminus. The regiospecificity of alcohol
hydroxylation was greatly improved by laboratory evolu-
tion. Conservative structural models of the P450BM3 vari-
ants demonstrate that the heme end residues in the
substrate-binding channel play a key role in determining
the regioselectivity for medium-chain alcohols. This study
not only provides a good strategy for the biosynthesis of
1,7-decanediol, but also gives a promising approach for
the production of other useful diols. More and more ad-




The P450BM3 gene was amplified from genomic DNA of
Bacillus megaterium ATCC 14581 (NZ_CP009920) with
the primer set BM3-NcoF and BM3-BamHR. The PCR
product digested with NcoI and BamHI was cloned into
pCOLADuet-1 (Novagen, Darmstadt, Germany) cut with
the same restriction enzymes, creating pLQ12. P450BM3J
was generated by introducing 10 amino acid mutations
(V78A, T175I, A184V, F205C, S226R, H236Q, E252G,
R255S, A290V, L353V) on P450BM3 [19]. The codon-
optimized 1129 bp necleic acids coding for the N-terminal
P450BM3J were chemically synthesized, amplified with the
primer set BM3J-NcoF and BM3J-EcoR, and integrated
into the pCOLADuet-1, creating the plasmid pZZ1-up.
The other part of the P450BM3J gene, which is the same as
that of P450BM3 gene, was amplified from genomic DNA
of B. megaterium (ATCC 14581) with the primer set
BM3J-EcoF and BM3J-NotR. The PCR product digested
with EcoRI and NotI was cloned into pZZ1-up cut with
the same restriction enzymes, creating pZZ1. The whole
P450BM3J gene sequence is shown in [Additional file 1:
Figure S1].
Structure modeling and site-directed mutagenesis
The models of the P450 variant structures were built on a
public server Swiss-Model, using 1FAG as the template
[22–24]. A method based on the amplification of the
entire plasmid using primers that include the desired
changes was employed for the site-directed mutagenesis
[25]. All the plasmids and strains used in this work are
listed in Table 1, and the oligonucleotide primers are given
in Table 2.
Table 1 Bacterial strains and plasmids used in this study
Plasmid or strain Relevant genotype or description Reference
Plasmids
pCOLADuet-1 ColA origin; KanR; PT7 Novagen
pLQ12 ColA origin; KanR; PT7:: P450BM3 This study
pZZ1 ColA origin; KanR; PT7:: P450BM3J This study
pV78A ColA origin; KanR; PT7:: P450BM3V78A This study
pT175I ColA origin; KanR; PT7:: P450BM3T175I This study
pA184V ColA origin; KanR; PT7:: P450BM3A184V This study
pF205C ColA origin; KanR; PT7:: P450BM3F205C This study
pS226R ColA origin; KanR; PT7:: P450BM3S226R This study
pH236Q ColA origin; KanR; PT7:: P450BM3H236Q This study
pE252G ColA origin; KanR; PT7:: P450BM3E252G This study
pR255S ColA origin; KanR; PT7:: P450BM3R255S This study
pA290V ColA origin; KanR; PT7:: P450BM3A290V This study
pL353V ColA origin; KanR; PT7:: P450BM3L353V This study
pJ2 ColA origin; KanR; PT7:: P450BM3JA78F This study
pJ2-R47L ColA origin; KanR; PT7:: P450BM3JA78FR47L This study
pJ2-F87A ColA origin; KanR; PT7:: P450BM3JA78F87A This study
Strains
BL21(DE3) E. coli B dcm ompT hsdS(rB
−mB
−) gal Invitrogen
LQ12 BL21(DE3) harboring pLQ12 This study
ZZ1 BL21(DE3) harboring pZZ1 This study
V78A BL21(DE3) harboring pV78A This study
T175I BL21(DE3) harboring pT175I This study
A184V BL21(DE3) harboring pA184V This study
F205C BL21(DE3) harboring pF205C This study
S226R BL21(DE3) harboring pS226R This study
H236Q BL21(DE3) harboring pH236Q This study
E252G BL21(DE3) harboring pE252G This study
R255S BL21(DE3) harboring pR255S This study
A290V BL21(DE3) harboring pA290V This study
L353V BL21(DE3) harboring pL353V This study
J2 BL21(DE3) harboring pJ2 This study
J2-R47L BL21(DE3) harboring pJ2-R47L This study
J2-F87A BL21(DE3) harboring pJ2-F87A This study
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Bacterial strains, media and growth conditions
The bacterial strains used in this study are listed in Table
S1. E. coli BL21(DE3) (Invitrogen, Carlsbad, CA) was used
as the host to overproduce proteins. During strain con-
struction, cultures were grown aerobically at 37 °C in LB
medium (10 g/L tryptone, 10 g/L NaCl, and 5 g/L yeast ex-
tract). Kanamycin (50 mg/L) was added if necessary. For
initial protein over-production in shake flasks, cultures
were firstly grown in LB medium containing 50 mg/L kana-
mycin, then induced with 0.5 mM isopropyl β-D-
thiogalactoside (IPTG), next incubated at 30 °C for 10 h,
and finally harvested by centrifugation. The cell catalysts
obtained from 50 ml cultures were transferred into
25 ml M9 medium (37.8 g/L Na2HPO4 · 12H2O,
7.5 g/L KH2PO4, 1 g/L NH4Cl, 0.5 g/L NaCl, 4 mM
MgSO4) supplemented with 50 mg/L kanamycin,
0.25 mM IPTG and 5 mM alcohols, and incubated at
30 °C for 48 h.
Analysis of diols by GC-MS
Different diols produced by the engineered strains were
identified by gas chromatography–mass spectrometry (GC–
MS). These diols were isolated by ethyl acetate extraction.
After concentrated by a rotary evaporator and redissolved
with ethanol, 1 μl sample was injected for GC-MS analysis.
The system consisted of model 7890A network GC system
(Agilent Technologies) and a model 5975C network mass
selective detector (Agilent Technologies, Santa Clara, CA).
A HP-INNOWAX capillary column (30 m× 0.25 mm;
0.25 μm film thickness; Agilent Technologies) was used,
with helium as the carrier gas. The following oven
temperature program was carried out: 50 °C for 2 min,
increase of 10 °C/min to 240 °C, 240 °C for 5 min. The
injector was maintained at 250 °C.
Additional file
Additional file 1: Figure S1. Nucleotide sequence of P450BM3J.
(DOCX 30 kb)
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